Distinct metabolic responses of an ovarian cancer stem cell line

[1]  Mark P. Styczynski,et al.  OVCAR-3 Spheroid-Derived Cells Display Distinct Metabolic Profiles , 2015, PloS one.

[2]  Imhoi Koo,et al.  MetPP: a computational platform for comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry-based metabolomics , 2013, Bioinform..

[3]  D. Maria,et al.  Synthetic phosphoethanolamine induces cell cycle arrest and apoptosis in human breast cancer MCF-7 cells through the mitochondrial pathway. , 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  Jan Paul Medema,et al.  Cancer stem cells: The challenges ahead , 2013, Nature Cell Biology.

[5]  D. Maria,et al.  Anti-Angiogenic and Anti-Metastatic Activity of Synthetic Phosphoethanolamine , 2013, PloS one.

[6]  A. Khurana,et al.  Metformin is synthetically lethal with glucose withdrawal in cancer cells , 2012, Cell cycle.

[7]  David S. Wishart,et al.  MetaboAnalyst 2.0—a comprehensive server for metabolomic data analysis , 2012, Nucleic Acids Res..

[8]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[9]  Lilya V. Matyunina,et al.  Isolation and characterization of stem-like cells from a human ovarian cancer cell line , 2011, Molecular and Cellular Biochemistry.

[10]  Lesley A. Mathews,et al.  The cancer stem cell niche—there goes the neighborhood? , 2011, International journal of cancer.

[11]  Joshua D. Knowles,et al.  Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry , 2011, Nature Protocols.

[12]  N. Nakaya,et al.  [Combination chemotherapy of docetaxel and UFT against hormone refractory prostate cancer]. , 2011, Hinyokika kiyo. Acta urologica Japonica.

[13]  L. Nicholson,et al.  Cancer stem cells: problems for therapy? , 2011, The Journal of pathology.

[14]  E. Negelein,et al.  THE METABOLISM OF CARCINOMA CELLS , 2011 .

[15]  Y. Chao,et al.  A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer , 2010, British Journal of Cancer.

[16]  Xin Lu,et al.  Metabolomic Changes Accompanying Transformation and Acquisition of Metastatic Potential in a Syngeneic Mouse Mammary Tumor Model* , 2010, The Journal of Biological Chemistry.

[17]  Chung-Pin Li,et al.  The unusual presentation of gastric adenocarcinoma as a testicular mass: a favorable response to docetaxel and Cisplatin plus oral tegafur/uracil and leucovorin. , 2010, Journal of the Chinese Medical Association : JCMA.

[18]  J. Rich,et al.  Hypoxia and hypoxia inducible factors in cancer stem cell maintenance. , 2010, Current topics in microbiology and immunology.

[19]  O. Fiehn,et al.  FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. , 2009, Analytical chemistry.

[20]  T. Ishikawa,et al.  Successful treatment of multiple lung metastases of hepatocellular carcinoma by combined chemotherapy with docetaxel, cisplatin and tegafur/uracil. , 2009, World journal of gastroenterology.

[21]  J. Visvader,et al.  Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.

[22]  Guido Kroemer,et al.  Tumor cell metabolism: cancer's Achilles' heel. , 2008, Cancer cell.

[23]  P Wadsworth,et al.  Taxol suppresses dynamics of individual microtubules in living human tumor cells. , 1999, Molecular biology of the cell.

[24]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[25]  O. Warburg,et al.  The Metabolism of Carcinoma Cells , 1925 .